Hemington Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$115K Buy
4,533
+1,672
+58% +$41.3K 0.01% 214
2025
Q2
$69K Sell
2,861
-324
-10% -$7.56K 0.01% 274
2025
Q1
$80K Buy
3,185
+304
+11% +$7.96K 0.01% 240
2024
Q4
$76K Sell
2,881
-301
-9% -$8.16K 0.02% 237
2024
Q3
$90K Buy
+3,182
New +$92.8K 0.02% 201

Other funds holding PFE

Hemington Wealth Management's PFE Position: Q3 2025 in Review

Hemington Wealth Management increased its Pfizer (PFE) stake by 58% in Q3 2025, buying an estimated $41.3K and bringing the position to 4,533 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #214.

Hemington Wealth Management first reported a position in PFE in Q3 2024 and has held it in 5 quarters since. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Hemington Wealth Management held 4,533 shares of Pfizer worth $115K as of Q3 2025.
  • Hemington Wealth Management bought 1,672 Pfizer shares in Q3 2025, an estimated $41.3K.
  • Pfizer made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #214 holding.
  • Hemington Wealth Management first reported a position in Pfizer in Q3 2024 and has held it in 5 quarters since.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.